Dr. Eydie Miller-Ellis is Professor of Clinical Ophthalmology and Director of the Glaucoma Service at the Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania. Dr. Miller-Ellis maintains a busy clinical practice in glaucoma and has lectured nationally and internationally on glaucoma diagnosis and management. She has excelled in the area of resident education, especially surgical training, and is a three-time recipient Surgical Teaching Award at the Scheie Eye Institute. Her research interests include risk factors for the development and progression of glaucoma, pharmacological and surgical treatment of glaucoma, and glaucoma genetics. In 2014, Dr. Miller-Ellis was elected to the Academy of Master Clinicians and in 2019 received the FOCUS Award for the Advancement of Women in Medicine, both at the University of Pennsylvania. She is recipient of the 2023 Outstanding Educator Award from the American Glaucoma Society. She is currently the Vice President/President Elect of the American Glaucoma Society. 

Financial disclosure: Dr. Eydie Miller-Ellis has/had an affiliation (financial or otherwise) with a commercial organization.

• Abbvie, Alcon, Thea Pharma, Horizon - Consultant, 
• Thea Pharma - Research funding
• Avisi Technologies - Advisor, stock options